Expres2ion Biotech Holding AB

At a glance

Most recent filing on October 9, 2026 — an open-market purchase by Bent Frandsen on Oct 9, 2026.

We hold 10 visible filings, going back to December 2, 2024.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

5 of 10 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 10. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Bent Frandsen Chief executive officer
11,000 SEKOpen-market buy
TradedOct 9, 2026FiledOct 9, 2026
Bent Frandsen Chief executive officer
11,000 SEKOpen-market buy
TradedOct 9, 2026FiledOct 9, 2026
Bent Frandsen Chief executive officer
9,200 SEKOpen-market buy
TradedOct 2, 2026FiledOct 2, 2026
Bent Frandsen Chief executive officer
14,280 SEKOpen-market buy
TradedOct 1, 2026FiledOct 2, 2026
Martin Roland Holding ApS Chair of the board
38,456 SEKOption exercise
TradedOct 2, 2025FiledOct 3, 2025